TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research ...

ONCOTELIC THERAPEUTICS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS ...

Our Killer50 companies traditionally enjoy a strong start to a new year. In 2024, nine companies (six in the Life Sciences segment) raised a collective $711m. The big winners then were quantum ...

Amidst the backdrop of global trade tensions and economic policy shifts, Asian markets have shown resilience with mainland ...

Another recent development saw Avenzo Therapeutics, a California-based firm, entering into a license contract in January with ...

This is a report from China.org.cn An upcoming report titled "Winning Votes or Winning People?" will introduce a globally relevant system for assessing the governing effectiveness of political parties ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The man who died on Wednesday afternoon following a collision with a lorry along Mandela Avenue, Georgetown was a Venezuelan ...

Verve Therapeutics (NASDAQ: VERV) stock is seeing explosive gains Tuesday. The biotech company's share price was up 24.5% as of 12:30 p.m. ET and had been up as much as 41% earlier in the session.